The difference between the credibility and the unambiguous disclosure of a therapeutic effect (T 0209/22)
The IPKat
JUNE 2, 2024
The recent Board of Appeal case T 0209/22 is yet another decision demonstrating the relatively permissive approach in Europe to medical use inventions. The patent related to the medical use of a combination of known drugs. The patent did not include any patient data for the drug combination.
Let's personalize your content